Company Profile
Cohance Lifesciences provides the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs globally.
The company offers small molecule APIs, advanced intermediates, and starting materials. Its portfolio also includes antibody drug conjugates, high-purity oligonucleotide building blocks comprising phosphoramidites, nucleosides, pseudouridine, NTPs, CAP reagents, GalNAc conjugates, and fluorescent dyes, pellets and finished dosage forms, and specialty chemicals
Including agrochemicals. The company serves pharmaceutical, biotechnology, and chemical companies. Founded in 1989 and headquartered in Hyderabad, India, the company was formerly known as Suven Pharmaceuticals Limited before rebranding in May 2025. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.